V

ViroGates A/S
CSE:VIRO

Watchlist Manager
ViroGates A/S
CSE:VIRO
Watchlist
Price: 15.4 DKK -6.67% Market Closed
Market Cap: 119.1m DKK
Have any thoughts about
ViroGates A/S?
Write Note

ViroGates A/S
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ViroGates A/S
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
V
ViroGates A/S
CSE:VIRO
Total Current Liabilities
kr1.7m
CAGR 3-Years
-16%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
GN Store Nord A/S
CSE:GN
Total Current Liabilities
kr13.4B
CAGR 3-Years
39%
CAGR 5-Years
24%
CAGR 10-Years
23%
Ambu A/S
CSE:AMBU B
Total Current Liabilities
kr1.1B
CAGR 3-Years
3%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Demant A/S
CSE:DEMANT
Total Current Liabilities
kr7.5B
CAGR 3-Years
-8%
CAGR 5-Years
-4%
CAGR 10-Years
4%
No Stocks Found

ViroGates A/S
Glance View

Market Cap
119.1m DKK
Industry
Health Care

ViroGates A/S develops and markets prognostic products for the healthcare sector. Its develops a product line suPARnostic, which measures the amount of amount of soluble urokinase Plasminogen Activator Receptor protein (suPAR) in human blood. The plasma level of suPAR reflects immune activation and is increased in such infectious diseases as HIV-1-infection, malaria, tuberculosis, Streptococcus pneumonia bacteraemia, sepsis, pneumococcal pneumonia and bacterial and viral CNS infection. Also, high suPAR levels are associated with increased inflammation, disease progression and risk of mortality. Thus, measuring suPAR levels serves as a marker to determine chances for survival upon hospital admission, as well as for monitoring for prevention of disease progression and earlier intervention time point. suPARnostic has two versions: Quantitative Point of Care Quick Triage test, which serves for patient triage in acute care, and Quantitative ELISA Assay that aims at clinical routine use.

VIRO Intrinsic Value
3.42 DKK
Overvaluation 78%
Intrinsic Value
Price
V

See Also

What is ViroGates A/S's Total Current Liabilities?
Total Current Liabilities
1.7m DKK

Based on the financial report for Sep 30, 2024, ViroGates A/S's Total Current Liabilities amounts to 1.7m DKK.

What is ViroGates A/S's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
-14%

Over the last year, the Total Current Liabilities growth was -14%. The average annual Total Current Liabilities growth rates for ViroGates A/S have been -16% over the past three years , -14% over the past five years .

Back to Top